Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-site, Open-Label, Pilot Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions

NCT03576469 is registered in ClinicalTrials.gov with IMMUNOe Research Centers as lead sponsor.

NCT NCT03576469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-site, Open-Label, Pilot Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions
Lead sponsor
IMMUNOe Research Centers
Phase
Phase 4
Overall status
Completed
Start date
June 13, 2018
Completion date
March 1, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cvi - common variable immunodeficiency